Pages that link to "Q80845843"
Jump to navigation
Jump to search
The following pages link to KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target (Q80845843):
Displaying 50 items.
- Early versus delayed erythropoietin for the anaemia of end-stage kidney disease (Q24187089) (← links)
- Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis (Q24187413) (← links)
- Early versus delayed erythropoietin for the anaemia of end-stage kidney disease (Q24194838) (← links)
- Erythropoiesis stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis (Q24201673) (← links)
- Hemoglobin targets for chronic kidney disease patients with anemia: a systematic review and meta-analysis (Q27023213) (← links)
- Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents (Q28727076) (← links)
- Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study. (Q31073395) (← links)
- Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials (Q33494136) (← links)
- Mild anemia is frequent and associated with micro- and macroangiopathies in patients with type 2 diabetes mellitus. (Q33585503) (← links)
- Secondary hyperparathyroidism and anemia in children treated by hemodialysis (Q33637678) (← links)
- Route of epoetin administration influences hemoglobin variability in hemodialysis patients. (Q33637889) (← links)
- The role of anemia management in improving outcomes for African-Americans with chronic kidney disease (Q33646679) (← links)
- Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? (Q33684085) (← links)
- Differential scaling of glomerular filtration rate and ingested metabolic burden: implications for gender differences in chronic kidney disease outcomes (Q33749281) (← links)
- Ethnic differences in anemia among patients with diabetes mellitus: the Diabetes Study of Northern California (DISTANCE). (Q33777603) (← links)
- Managing anemia in patients with chronic heart failure: what do we know? (Q33797640) (← links)
- Sodium gradient, xerostomia, thirst and inter-dialytic excessive weight gain: a possible relationship with hyposalivation in patients on maintenance hemodialysis (Q33810616) (← links)
- End-stage renal disease (Q33850437) (← links)
- Extended dosing of darbepoetin alfa in peritoneal dialysis patients (Q33854988) (← links)
- Primary care of the renal transplant patient. (Q33898744) (← links)
- Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis (Q33906186) (← links)
- The association of chronic kidney disease complications by albuminuria and glomerular filtration rate: a cross-sectional analysis (Q33939290) (← links)
- Health-related quality of life outcomes in chronic kidney disease (Q33976245) (← links)
- Survival analysis of patients on maintenance hemodialysis (Q33991365) (← links)
- The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study (Q34000965) (← links)
- Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis (Q34133189) (← links)
- Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients (Q34281518) (← links)
- Safety and Efficacy of PDpoetin for Management of Anemia in Patients with end Stage Renal Disease on Maintenance Hemodialysis: Results from a Phase IV Clinical Trial (Q34325810) (← links)
- Association Between Clinical Risk Factors and Progression of Chronic Kidney Disease in Children (Q34362651) (← links)
- Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. (Q34399172) (← links)
- Stable hemoglobin in hemodialysis patients: forest for the trees--a 12-week pilot observational study (Q34493460) (← links)
- Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients (Q34534923) (← links)
- Age and anemia management: relationship of hemoglobin levels with mortality might differ between elderly and nonelderly hemodialysis patients (Q34555348) (← links)
- Kidney disease: improving global outcomes (Q34659157) (← links)
- Monitoring of hemodialysis quality-of-care indicators: why is it important? (Q34738880) (← links)
- Hemoglobin differences by race in children with CKD. (Q34990962) (← links)
- Diagnosis of cardiac disease in pediatric end-stage renal disease (Q35133086) (← links)
- Association between the Hemoglobin Level and Cardiothoracic Ratio in Patients on Incident Dialysis. (Q35134442) (← links)
- Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST) (Q35151878) (← links)
- Do two intravenous iron sucrose preparations have the same efficacy? (Q35344826) (← links)
- Clinical use of erythropoietin in chronic kidney disease: outcomes and future prospects. (Q35530060) (← links)
- Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis (Q35664160) (← links)
- Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents (Q35670734) (← links)
- Resistance of dialyzed patients to erythropoietin (Q35694046) (← links)
- Dosing of erythropoiesis-stimulating agents can be reduced by a new administration regimen (Q35791818) (← links)
- Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients (Q35851384) (← links)
- Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. (Q35857178) (← links)
- Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis (Q35904444) (← links)
- Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study (Q35936604) (← links)
- Anemia in type 2 diabetic patients and correlation with kidney function in a tertiary care sub-Saharan African hospital: a cross-sectional study (Q35963807) (← links)